SBC Medical Group Holdings Incorporated Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
SBC Medical Group Holdings Incorporated (SBC) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$253.63 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-19.
Discontinued › Notes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2024-03-19
- SBC Medical Group Holdings Incorporated valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was -$253.63K.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 10 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|---|
| 2023-12-31 | -$253.63K 10-K · filed 2024-03-19 | |
| 2022-12-31 | -$80.23K 10-K · filed 2024-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |